Meyka Pro banner
BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) Stock Overview

Explore BioLife Solutions, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BLFSNASDAQ
HealthcareMedical - Instruments & Supplies
$29.98
$0.79(2.57%)
U.S. Market opens in 14h 27m

BioLife Solutions, Inc. (BLFS)

Meyka AI Score

Z

Key Financials

Market Cap1.5B
P/E Ratio-140.13
EPS (TTM)$-0.21
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$31.14
3 Months$28.64
1 Year Target$28.93

BLFS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of BioLife Solutions, Inc. (NASDAQ: BLFS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BioLife Solutions, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BLFS on the NASDAQ shows an RSI of 61.50, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $28.93 for the NASDAQ listing.

Key metrics behind BioLife Solutions, Inc.'s NASDAQ-traded stock include a P/E ratio of -140.13 and a market capitalization of 1.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BLFS on the NASDAQ.

Price Performance (NASDAQ: BLFS)

1-Day Change
-2.57%
5-Day Change
-0.07%
1-Month Change
17.25%
3-Month Change
40.22%
6-Month Change
20.55%
Year-to-Date (YTD) Change
23.99%
1-Year Change
34.68%
3-Year Change
53.43%
5-Year Change
-33.76%
All-Time (Max) Change
-71.45%

Contact Information

425 402 1400
3303 Monte Villa Parkway, Bothell, WA, 98021

Company Facts

1,550 Employees
IPO DateNov 22, 1989
CountryUS
Actively Trading

Frequently Asked Questions